A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Clinical trial NCT02951598 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02951598
Sponsor: Eli Lilly and Company
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Alzheimer Disease Mild Cognitive Impairment

Start date: 2016-10-29
Primary completion: 2021-01-30
Enrollment: 1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.